Hutchens & Kramer Investment Management Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Hold
1,547
0.12% 92
2026
Q1
$413K Hold
1,547
0.13% 90
2025
Q4
$388K Sell
1,547
-11
-0.7% -$2.92K 0.13% 97
2025
Q3
$447K Buy
1,558
+11
+0.7% +$2.95K 0.18% 84
2025
Q2
$409K Hold
1,547
0.19% 86
2025
Q1
$360K Hold
1,547
0.2% 84
2024
Q4
$355K Hold
1,547
0.19% 90
2024
Q3
$339K Hold
1,547
0.19% 97
2024
Q2
$314K Hold
1,547
0.17% 98
2024
Q1
$335K Hold
1,547
0.2% 83
2023
Q4
$352K Hold
1,547
0.25% 69
2023
Q3
$309K Sell
1,547
-254
-14% -$53.6K 0.25% 74
2023
Q2
$373K Hold
1,801
0.3% 63
2023
Q1
$355K Sell
1,801
-1,800
-50% -$370K 0.31% 63
2022
Q4
$729K Hold
3,601
0.53% 45
2022
Q3
$655K Hold
3,601
0.53% 41
2022
Q2
$745K Hold
3,601
0.55% 44
2022
Q1
$814K Hold
3,601
0.45% 55
2021
Q4
$858K Buy
+3,601
New +$891K 0.54% 44

Other funds holding LH

Hutchens & Kramer Investment Management Group's LH Position: Q2 2026 in Review

Hutchens & Kramer Investment Management Group held its Labcorp (LH) position steady in Q2 2026 at 1,547 shares worth $433K. The position accounts for 0.12% of the portfolio, ranked #92.

Hutchens & Kramer Investment Management Group first reported a position in LH in Q4 2021 and has held it in 19 quarters since. The position peaked at $858K in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Hutchens & Kramer Investment Management Group held 1,547 shares of Labcorp worth $433K as of Q2 2026.
  • Hutchens & Kramer Investment Management Group left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.12% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #92 holding.
  • Hutchens & Kramer Investment Management Group first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
  • Hutchens & Kramer Investment Management Group's Labcorp position peaked at $858K in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.